| Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab AR Morrison, JM Johnson, KM Griebe, MC Jones, JJ Stine, LN Hencken, ... Journal of autoimmunity 114, 102512, 2020 | 76 | 2020 |
| Discharge delays and costs associated with outpatient parenteral antimicrobial therapy for high-priced antibiotics ML Bianchini, RM Kenney, R Lentz, M Zervos, M Malhotra, SL Davis Clinical Infectious Diseases 71 (7), e88-e93, 2020 | 17 | 2020 |
| Improving care for critically ill patients with community-acquired pneumonia ML Bianchini, NJ Mercuro, RM Kenney, MA Peters, LP Samuel, ... American journal of health-system pharmacy 76 (12), 861-868, 2019 | 10 | 2019 |
| Risk factors associated with opioid/benzodiazepine iatrogenic withdrawal syndrome in COVID-19 acute respiratory distress syndrome MV Maffei, S Laehn, M Bianchini, A Kim Journal of Pharmacy Practice 36 (6), 1362-1369, 2023 | 4 | 2023 |
| Cost-Effectiveness Analysis of New Beta-Lactam Beta-Lactamase Inhibitor Antibiotics Versus Colistin for the Treatment of Carbapenem-Resistant Infections ML Bianchini, MN Jeffres, JD Campbell Hospital Pharmacy 57 (1), 93-100, 2022 | 3 | 2022 |
| 601: PHARMACY-DRIVEN INITIATIVE IMPROVES CARE FOR SEVERE COMMUNITY-ACQUIRED PNEUMONIA M Bianchini, N Mercuro, R Kenney, M Peters, J Swiderek, L Samuel, ... Critical Care Medicine 47 (1), 281, 2019 | 1 | 2019 |
| EPH173 Estimating the Utilization of Doxycycline Post-Exposure Prophylaxis (DoxyPEP) and the Impact on Syphilis Rates in Colorado M Bianchini, HD Anderson, SE Rowan, HM Frost, R Valuck, R McQueen Value in Health 27 (6), S184, 2024 | | 2024 |
| Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database ML Bianchini, CL Aquilante, DP Kao, JL Martin, HD Anderson Journal of Personalized Medicine 13 (11), 1574, 2023 | | 2023 |
| P75 Impact of High-Dose Vs Standard-Dose Influenza Vaccine on Respiratory Hospitalizations Among Adults M Bianchini, GC Wright, HD Anderson, MC Perraillon, RC Lindrooth Value in Health 25 (7), S303, 2022 | | 2022 |
| Delay increases costs of parenteral antibacterials in outpatients ML Bianchini PharmacoEconomics & Outcomes News 841, 13-16, 2019 | | 2019 |
| 772. Access Denied: Impact of Insurance Denials for High-Cost Outpatient Parenteral Antimicrobial Therapy. ML Bianchini, R Kenney, R Lentz, M Zervos, M Malhotra, SL Davis Open Forum Infectious Diseases 6, 2019 | | 2019 |
| 2030. Impact of an Antimicrobial Stewardship Program on Carbapenem Susceptibility in a National Hospital in Bhutan. P Chuki, ML Bianchini, T Tshering, R Sharma, P Yangzom, U Dema, ... Open Forum Infectious Diseases 6, 2019 | | 2019 |
